全球基因组医学市场 – 2029 年行业趋势及预测

基因组医学市场分析和规模

专门利用 DNA、蛋白质谱及其功能等遗传数据，同时了解它们如何与人类健康相互作用而开发的药物被称为基因组药物，也称为个性化药物。这些药物能够揭示一个人的正常生物学事实，然后可用于制定适当的患者治疗方案和药物。

Data Bridge Market Research 分析认为，基因组医学市场规模在 2021 年为 230.8 亿美元，到 2029 年将飙升至 756.7 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 16.00%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

基因组医学市场范围和细分      

市场定义

The branch of science known as genomic medicine examines our DNA and how it interacts with our health using genomic data. They are able to gather information about a person's usual biological characteristics and use it to provide successful treatment.

Genomic Medicine Market Dynamics

Drivers

• Technological Advancements

Technology advancements and the potential for further research into the identification and monitoring of other biomarkers that may potentially be utilised for pharmacogenomics are other factors supporting the expansion of the global market for genomic medicine during the next five years.

• Rise in government spending on medicines

Growing government spending on precision medicine is anticipated to fuel industry expansion. The market for genomic medicine will grow faster from 2022 to 2029 due to other factors such as expanding genomic application areas, growing numbers of genomics projects, and rising demand for enhanced sequencing in cancer, pharmacogenomics, and rare condition detection.

• Rise in pharmaceuticals

The global market for genomic medicines will rise over the next five years due to rising research and advancements in the pharmaceutical business. The expansion of the worldwide market for genomic medicine in the ensuing five years will also be supported by growing government initiatives, individual investments, and an increase in the uses of genomic studies in the healthcare industry.

Opportunities

• Increase in the number of research and development activities 

The market's growth is fuelled by an increasing scientific research on genomic medicine. This will provide beneficial opportunities for the market growth.

Restraints/Challenges

The lack of adoption of genomic medicine, the instability of the regulatory environment, and the lack of provider awareness will restrain market expansion.

This genomic medicine market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the genomic medicine market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Genomic Medicine Market

The COVID-19 pandemic has considerably impacted the global market for genomic medicine in 2020. The COVID-19 outbreak has impacted various factors, including aircraft cancellations, quarantines, travel prohibitions, restaurant closures, and restrictions on all indoor and outdoor events. More than fifty nations declared lockdown and a health emergency resulted in a sharp decline in business confidence, escalating public panic, and future uncertainty.

Global Genomic Medicine Market Scope

The genomic medicine market is segmented on the basis of application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Application

• Oncology
• Cardiology
• Paediatrics
• Endocrinology
• Respiratory Medicine
• Rare Genetic Disorders
• Infectious Diseases
• Others

End- User

• Hospitals
• Clinics
• Academic Institutions
• Research Institutions

Genomic Medicine Market Regional Analysis/Insights

The genomic medicine market is analysed and market size insights and trends are provided by country, application and end-user as referenced above.

The countries covered in the genomic medicine market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the genomic medicine market due to increasing R&D in the genomic medicine and availability of various universities offering education programs on genomic medicine.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness among the people and growing demand of advanced medical technology.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Genomic Medicine Market Share Analysis

基因组医学市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对基因组医学市场的关注有关。

基因组医学市场的一些主要参与者包括：

• Genome Medical, Inc.（美国）
• BioMed Central Ltd（英国）
• Aevi Genomic Medicine, Inc.（以色列）
• Congenica Ltd.（英国）
• Deep Genomics（加拿大）
• Editas Medicine（美国）
• 克利夫兰诊所（美国）
• Illumina 公司（美国）
• 赛默飞世尔科技（美国）
• QIAGEN NV（荷兰）
• 安捷伦科技公司（美国）
• Bio-Rad Laboratories, Inc.（美国）
• F. Hoffmann-La Roche Ltd.（瑞士）
• 华大基因（中国）

SKU-52824